Background: Coagulation disturbances and hemorrhage are common in critically ill pediatric
patients especially those with intracranial pathology or traumatic brain injury (TBI). Even with …

Coagulation disturbances frequently occur in critically ill children. Four-factor prothrombin
complex concentrate (4F-PCC) may have a potential role in managing these patients while …

Background: To date, clinical experience with prothrombin complex concentrate (PCC) in
the neonatal population has been limited. Aim: The objective of this study was to describe …

To systematically evaluate the effectiveness of prothrombin complex concentrate (PCC) in
neonates and infants, we performed a systematic review and meta-analysis based on …

Prothrombin complex concentrates (PCCs) are used to manage bleeding in critically ill
children. We performed a repeat cross-sectional study using the Pediatric Health Information …

Pre hospital administration of prothrombin complex concentrate in the head injured patient,
a service evaluation Page 1 MEETING ABSTRACT Open Access Pre hospital …

Abstract Background/Introduction: 4-factor prothrombin complex concentrate (PCC) is
currently approved in the United States for the urgent reversal of warfarin-induced …

BACKGROUND Coagulopathy in patients with traumatic brain injury (TBI) is a well-studied
concept. Prothrombin complex concentrate (PCC) has been shown to be an effective …

The Fig. 1 in the original version of the above article contained errors. The number of" Full-
text articles excluded, with reasons" should have been 181 rather than 180 and as the …

BACKGROUND: Prothrombin complex concentrate (PCC) is an inactivated concentrate of
factors II, IX, and X, with variable amounts of factor VII. Guidelines recommend the use of …